General Information of the Compound
Compound ID
CP0200237
Compound Name
1-(2-(benzyloxy)phenethyl)-3-methoxybenzene
    Show/Hide
Synonyms
1-(benzyloxy)-2-[2-(3-methoxyphenyl)ethyl]benzene
BDBM50197201
CHEMBL214739
    Show/Hide
Structure
Formula
C22H22O2
Molecular Weight
318.416
Canonical SMILES
COc1cccc(CCc2ccccc2OCc2ccccc2)c1
    Show/Hide
InChI
InChI=1S/C22H22O2/c1-23-21-12-7-10-18(16-21)14-15-20-11-5-6-13-22(20)24-17-19-8-3-2-4-9-19/h2-13,16H,14-15,17H2,1H3
    Show/Hide
InChIKey
SDDBNQDQBZPCGB-UHFFFAOYSA-N
Physicochemical Property
logP
5.0594
Rotatable Bonds
7
Heavy Atom Count
24
Polar Areas
18.46
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11973927
SID: 17425773
ChEMBL ID
CHEMBL214739
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000034 Caco-2 Homo sapiens (Human)  1
1
EC50 = 92800 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-(benzyloxy)-2-[2-(3-methoxyphenyl)ethyl]benzene )
Drug Name 1-(benzyloxy)-2-[2-(3-methoxyphenyl)ethyl]benzene
Target(s)
5-HT 1A receptor (HTR1A)
Inhibitor
Dopamine D2 receptor (D2R)
Inhibitor